QURE Stock Analysis: Buy, Sell, or Hold?
QURE - uniQure N.V.
$22.72
-0.94 (-3.95%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Smart Money Accumulation
QURE is down 9.4% this week, but smart money is accumulating calls. Top strike: $30 2026-04-17 with 14,163 OI. Call ratio: 89% View Scanner →
Strength: 8.6/10
Get Alerted When QURE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called QURE this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: QURE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: QURE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: QURE is currently trading at $22.72, which is considered slightly low relative to its 30-day fair value range of $22.34 to $24.60.
Technical Outlook: Technically, QURE is in a downtrend. Immediate support is located at $21.64, while resistance sits at $25.80. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $54.12 (+128.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, QURE is in a downtrend. Immediate support is located at $21.64, while resistance sits at $25.80. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $54.12 (+128.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$22.34 -
$24.60
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Protect Your Profits
Holding QURE? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.0%)
- BULLISH: Trading 128.8% below Wall St target ($54.12)
- CAUTION: Recommendation downgraded due to -9.4% 5-day decline
Fair Price Analysis
30-Day Fair Range
$22.34 -
$24.60
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$21.64
Resistance Level
$25.80
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-8.52
Wall Street Target
$54.12
(+128.8%)
Revenue Growth (YoY)
61.8%
Earnings Growth (YoY)
-18.2%
Last updated: January 31, 2026 8:32 AM ET
Data refreshes hourly during market hours. Next update: 9:32 AM
Data refreshes hourly during market hours. Next update: 9:32 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QURE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Christian Klemt
SELL
15000 shares
2025-09-26
Christian Klemt
SELL
3000 shares
2025-09-24
Matthew C Kapusta
SELL
226316 shares
2025-09-24
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$90 | 59 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$35 | 51 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$65 | 60 HOLD |
Advanced QURE Option Strategies
Professional options setups generated by AI based on today's QURE price and gamma walls.